Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 30 studies | 35% ± 14% | |
astrocyte | 20 studies | 50% ± 19% | |
epithelial cell | 13 studies | 35% ± 21% | |
type I pneumocyte | 12 studies | 44% ± 14% | |
type II pneumocyte | 12 studies | 37% ± 16% | |
oligodendrocyte | 11 studies | 32% ± 13% | |
pericyte | 11 studies | 30% ± 10% | |
vein endothelial cell | 11 studies | 29% ± 12% | |
oligodendrocyte precursor cell | 11 studies | 35% ± 16% | |
capillary endothelial cell | 11 studies | 35% ± 13% | |
ciliated cell | 9 studies | 29% ± 12% | |
endothelial cell of artery | 8 studies | 33% ± 12% | |
basal cell | 8 studies | 34% ± 13% | |
endothelial cell of lymphatic vessel | 8 studies | 21% ± 5% | |
fibroblast | 8 studies | 24% ± 5% | |
macrophage | 6 studies | 19% ± 3% | |
club cell | 6 studies | 33% ± 12% | |
endothelial cell of vascular tree | 5 studies | 27% ± 7% | |
Mueller cell | 5 studies | 29% ± 12% | |
abnormal cell | 5 studies | 46% ± 16% | |
secretory cell | 4 studies | 37% ± 16% | |
connective tissue cell | 4 studies | 22% ± 5% | |
enterocyte | 4 studies | 23% ± 3% | |
glial cell | 4 studies | 22% ± 8% | |
smooth muscle cell | 4 studies | 20% ± 4% | |
luminal hormone-sensing cell of mammary gland | 4 studies | 19% ± 3% | |
hepatocyte | 4 studies | 54% ± 29% | |
dendritic cell | 4 studies | 29% ± 12% | |
goblet cell | 4 studies | 37% ± 19% | |
ionocyte | 3 studies | 26% ± 4% | |
conventional dendritic cell | 3 studies | 27% ± 6% | |
podocyte | 3 studies | 56% ± 13% | |
progenitor cell | 3 studies | 21% ± 3% | |
extravillous trophoblast | 3 studies | 28% ± 17% | |
retinal pigment epithelial cell | 3 studies | 31% ± 16% | |
mesothelial cell | 3 studies | 28% ± 16% | |
pancreatic ductal cell | 3 studies | 47% ± 15% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 9317.63 | 2635 / 2642 | 100% | 280.01 | 703 / 705 |
ovary | 100% | 2853.36 | 180 / 180 | 99% | 59.48 | 427 / 430 |
liver | 100% | 7611.80 | 226 / 226 | 99% | 120.34 | 402 / 406 |
lung | 100% | 9690.26 | 578 / 578 | 98% | 110.08 | 1136 / 1155 |
breast | 100% | 4016.78 | 459 / 459 | 98% | 68.09 | 1095 / 1118 |
intestine | 100% | 4324.45 | 965 / 966 | 97% | 71.44 | 513 / 527 |
prostate | 100% | 3058.18 | 244 / 245 | 95% | 34.69 | 479 / 502 |
thymus | 100% | 2977.44 | 651 / 653 | 95% | 58.87 | 573 / 605 |
esophagus | 99% | 2787.03 | 1435 / 1445 | 95% | 61.17 | 174 / 183 |
skin | 100% | 3434.83 | 1807 / 1809 | 94% | 63.87 | 446 / 472 |
uterus | 100% | 3225.53 | 170 / 170 | 92% | 44.12 | 421 / 459 |
kidney | 100% | 3884.91 | 89 / 89 | 92% | 70.63 | 826 / 901 |
bladder | 100% | 2840.67 | 21 / 21 | 92% | 56.99 | 462 / 504 |
adrenal gland | 100% | 10422.80 | 258 / 258 | 91% | 57.56 | 210 / 230 |
stomach | 82% | 1867.74 | 296 / 359 | 94% | 65.18 | 270 / 286 |
pancreas | 75% | 1233.20 | 247 / 328 | 98% | 69.60 | 174 / 178 |
adipose | 100% | 3365.29 | 1202 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 98% | 2412.45 | 1314 / 1335 | 0% | 0 | 0 / 0 |
spleen | 98% | 1985.40 | 235 / 241 | 0% | 0 | 0 / 0 |
heart | 93% | 2248.52 | 797 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 80% | 28.78 | 36 / 45 |
eye | 0% | 0 | 0 / 0 | 54% | 16.62 | 43 / 80 |
muscle | 30% | 391.17 | 237 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 3% | 37.47 | 27 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0009636 | Biological process | response to toxic substance |
GO_1901335 | Biological process | lactone catabolic process |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0102007 | Molecular function | acyl-L-homoserine-lactone lactonohydrolase activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0004064 | Molecular function | arylesterase activity |
Gene name | PON2 |
Protein name | Paraoxonase 2 Serum paraoxonase/arylesterase 2 (PON 2) (EC 3.1.1.2) (EC 3.1.1.81) (Aromatic esterase 2) (A-esterase 2) (Serum aryldialkylphosphatase 2) Paraoxonase (EC 3.1.1.2) |
Synonyms | hCG_1640820 |
Description | FUNCTION: Capable of hydrolyzing lactones and a number of aromatic carboxylic acid esters. Has antioxidant activity. Is not associated with high density lipoprotein. Prevents LDL lipid peroxidation, reverses the oxidation of mildly oxidized LDL, and inhibits the ability of MM-LDL to induce monocyte chemotaxis. . |
Accessions | ENST00000455123.5 ENST00000632034.1 ENST00000483292.5 ENST00000493290.5 ENST00000478801.5 ENST00000490778.5 G3XAK4 A0A2Q2SAK4 ENST00000222572.8 [Q15165-2] A0A0J9YXU7 A0A0J9YYF3 ENST00000469926.5 ENST00000633192.1 ENST00000491069.5 ENST00000633531.1 [Q15165-2] Q6PJZ2 ENST00000433091.6 [Q15165-3] A0A0J9YXM1 ENST00000446142.5 A0A0J9YVW3 A0A0J9YXF2 Q15165 A0A0J9YYJ1 A0A0J9YYF0 |